Global Pediatric Drugs and Vaccines Market Growth 2021-2026
According to this latest study, the 2021 growth of Pediatric Drugs and Vaccines will have significant change from previous year. By the most conservative estimates of global Pediatric Drugs and Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 93410 million in 2020. Over the next five years the Pediatric Drugs and Vaccines market will register a 9.4% CAGR in terms of revenue, the global market size will reach US$ 133690 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Pediatric Drugs and Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Newborn
Infant
Child
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pediatric Drugs and Vaccines Consumption 2016-2026
2.1.2 Pediatric Drugs and Vaccines Consumption CAGR by Region
2.2 Pediatric Drugs and Vaccines Segment by Type
2.2.1 Diphtheria
2.2.2 Influenza
2.2.3 Hepatitis
2.2.4 Pneumococcal Diseases
2.2.5 Meningococcal Diseases
2.2.6 Mumps
2.2.7 Others
2.3 Pediatric Drugs and Vaccines Sales by Type
2.3.1 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021)
2.3.2 Global Pediatric Drugs and Vaccines Revenue and Market Share by Type (2016-2021)
2.3.3 Global Pediatric Drugs and Vaccines Sale Price by Type (2016-2021)
2.4 Pediatric Drugs and Vaccines Segment by Application
2.4.1 Newborn
2.4.2 Infant
2.4.3 Child
2.5 Pediatric Drugs and Vaccines Sales by Application
2.5.1 Global Pediatric Drugs and Vaccines Sale Market Share by Application (2016-2021)
2.5.2 Global Pediatric Drugs and Vaccines Revenue and Market Share by Application (2016-2021)
2.5.3 Global Pediatric Drugs and Vaccines Sale Price by Application (2016-2021)
3 Global Pediatric Drugs and Vaccines by Company
3.1 Global Pediatric Drugs and Vaccines Sales Market Share by Company
3.1.1 Global Pediatric Drugs and Vaccines Sales by Company (2019-2021)
3.1.2 Global Pediatric Drugs and Vaccines Sales Market Share by Company (2019-2021)
3.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Company
3.2.1 Global Pediatric Drugs and Vaccines Revenue by Company (2019-2021)
3.2.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Company (2019-2021)
3.3 Global Pediatric Drugs and Vaccines Sale Price by Company
3.4 Global Manufacturers Pediatric Drugs and Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pediatric Drugs and Vaccines Product Location Distribution
3.4.2 Players Pediatric Drugs and Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Pediatric Drugs and Vaccines by Region
4.1 Global Pediatric Drugs and Vaccines by Region
4.1.1 Global Pediatric Drugs and Vaccines Sales by Region
4.1.2 Global Pediatric Drugs and Vaccines Revenue by Region
4.2 Americas Pediatric Drugs and Vaccines Sales Growth
4.3 APAC Pediatric Drugs and Vaccines Sales Growth
4.4 Europe Pediatric Drugs and Vaccines Sales Growth
4.5 Middle East & Africa Pediatric Drugs and Vaccines Sales Growth
5 Americas
5.1 Americas Pediatric Drugs and Vaccines Sales by Country
5.1.1 Americas Pediatric Drugs and Vaccines Sales by Country (2016-2021)
5.1.2 Americas Pediatric Drugs and Vaccines Revenue by Country (2016-2021)
5.2 Americas Pediatric Drugs and Vaccines Sales by Type
5.3 Americas Pediatric Drugs and Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pediatric Drugs and Vaccines Sales by Region
6.1.1 APAC Pediatric Drugs and Vaccines Sales by Region (2016-2021)
6.1.2 APAC Pediatric Drugs and Vaccines Revenue by Region (2016-2021)
6.2 APAC Pediatric Drugs and Vaccines Sales by Type
6.3 APAC Pediatric Drugs and Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pediatric Drugs and Vaccines by Country
7.1.1 Europe Pediatric Drugs and Vaccines Sales by Country (2016-2021)
7.1.2 Europe Pediatric Drugs and Vaccines Revenue by Country (2016-2021)
7.2 Europe Pediatric Drugs and Vaccines Sales by Type
7.3 Europe Pediatric Drugs and Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pediatric Drugs and Vaccines by Country
8.1.1 Middle East & Africa Pediatric Drugs and Vaccines Sales by Country (2016-2021)
8.1.2 Middle East & Africa Pediatric Drugs and Vaccines Revenue by Country (2016-2021)
8.2 Middle East & Africa Pediatric Drugs and Vaccines Sales by Type
8.3 Middle East & Africa Pediatric Drugs and Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Pediatric Drugs and Vaccines Distributors
10.3 Pediatric Drugs and Vaccines Customer
11 Global Pediatric Drugs and Vaccines Market Forecast
11.1 Global Pediatric Drugs and Vaccines Forecast by Region
11.1.1 Global Pediatric Drugs and Vaccines Forecast by Regions (2021-2026)
11.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Pediatric Drugs and Vaccines Forecast by Type
11.7 Global Pediatric Drugs and Vaccines Forecast by Application
12 Key Players Analysis
12.1 Merck & Co., Inc. (USA)
12.1.1 Merck & Co., Inc. (USA) Company Information
12.1.2 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Offered
12.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Merck & Co., Inc. (USA) Main Business Overview
12.1.5 Merck & Co., Inc. (USA) Latest Developments
12.2 Abbott Laboratories (USA)
12.2.1 Abbott Laboratories (USA) Company Information
12.2.2 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Offered
12.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Abbott Laboratories (USA) Main Business Overview
12.2.5 Abbott Laboratories (USA) Latest Developments
12.3 Amgen, Inc. (USA)
12.3.1 Amgen, Inc. (USA) Company Information
12.3.2 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Offered
12.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Amgen, Inc. (USA) Main Business Overview
12.3.5 Amgen, Inc. (USA) Latest Developments
12.4 Eli Lilly and Company (USA)
12.4.1 Eli Lilly and Company (USA) Company Information
12.4.2 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Offered
12.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Eli Lilly and Company (USA) Main Business Overview
12.4.5 Eli Lilly and Company (USA) Latest Developments
12.5 F. Hoffmann-La Roche Ltd (Switzerland)
12.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Information
12.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Offered
12.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Main Business Overview
12.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Latest Developments
12.6 Genentech, Inc. (USA)
12.6.1 Genentech, Inc. (USA) Company Information
12.6.2 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Offered
12.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Genentech, Inc. (USA) Main Business Overview
12.6.5 Genentech, Inc. (USA) Latest Developments
12.7 GlaxoSmithKline plc. (UK)
12.7.1 GlaxoSmithKline plc. (UK) Company Information
12.7.2 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Offered
12.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 GlaxoSmithKline plc. (UK) Main Business Overview
12.7.5 GlaxoSmithKline plc. (UK) Latest Developments
12.8 Janssen Biologics B.V. (USA)
12.8.1 Janssen Biologics B.V. (USA) Company Information
12.8.2 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Offered
12.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Janssen Biologics B.V. (USA) Main Business Overview
12.8.5 Janssen Biologics B.V. (USA) Latest Developments
12.9 Actelion Pharmaceuticals
12.9.1 Actelion Pharmaceuticals Company Information
12.9.2 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Offered
12.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Actelion Pharmaceuticals Main Business Overview
12.9.5 Actelion Pharmaceuticals Latest Developments
12.10 AstraZeneca Plc. (UK)
12.10.1 AstraZeneca Plc. (UK) Company Information
12.10.2 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Offered
12.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 AstraZeneca Plc. (UK) Main Business Overview
12.10.5 AstraZeneca Plc. (UK) Latest Developments
12.11 Boehringer Ingelheim GmbH (Germany)
12.11.1 Boehringer Ingelheim GmbH (Germany) Company Information
12.11.2 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Offered
12.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Boehringer Ingelheim GmbH (Germany) Main Business Overview
12.11.5 Boehringer Ingelheim GmbH (Germany) Latest Developments
12.12 Bristol-Myers Squibb Company (USA)
12.12.1 Bristol-Myers Squibb Company (USA) Company Information
12.12.2 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Offered
12.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Bristol-Myers Squibb Company (USA) Main Business Overview
12.12.5 Bristol-Myers Squibb Company (USA) Latest Developments
12.13 Allergan, Inc. (USA)
12.13.1 Allergan, Inc. (USA) Company Information
12.13.2 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Offered
12.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Allergan, Inc. (USA) Main Business Overview
12.13.5 Allergan, Inc. (USA) Latest Developments
12.14 Novartis AG (Switzerland)
12.14.1 Novartis AG (Switzerland) Company Information
12.14.2 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Offered
12.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Novartis AG (Switzerland) Main Business Overview
12.14.5 Novartis AG (Switzerland) Latest Developments
12.15 Novo Nordisk A/S (Denmark)
12.15.1 Novo Nordisk A/S (Denmark) Company Information
12.15.2 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Offered
12.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Novo Nordisk A/S (Denmark) Main Business Overview
12.15.5 Novo Nordisk A/S (Denmark) Latest Developments
12.16 Pfizer, Inc. (USA)
12.16.1 Pfizer, Inc. (USA) Company Information
12.16.2 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Offered
12.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Pfizer, Inc. (USA) Main Business Overview
12.16.5 Pfizer, Inc. (USA) Latest Developments
12.17 Sanofi S.A (France)
12.17.1 Sanofi S.A (France) Company Information
12.17.2 Sanofi S.A (France) Pediatric Drugs and Vaccines Product Offered
12.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Sanofi S.A (France) Main Business Overview
12.17.5 Sanofi S.A (France) Latest Developments
12.18 Shionogi Inc. (USA)
12.18.1 Shionogi Inc. (USA) Company Information
12.18.2 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Offered
12.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 Shionogi Inc. (USA) Main Business Overview
12.18.5 Shionogi Inc. (USA) Latest Developments
12.19 Takeda
12.19.1 Takeda Company Information
12.19.2 Takeda Pediatric Drugs and Vaccines Product Offered
12.19.3 Takeda Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 Takeda Main Business Overview
12.19.5 Takeda Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Pediatric Drugs and Vaccines Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Diphtheria
Table 3. Major Players of Influenza
Table 4. Major Players of Hepatitis
Table 5. Major Players of Pneumococcal Diseases
Table 6. Major Players of Meningococcal Diseases
Table 7. Major Players of Mumps
Table 8. Major Players of Others
Table 9. Global Pediatric Drugs and Vaccines Sales by Type (2016-2021) & (Kg)
Table 10. Global Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021)
Table 11. Global Pediatric Drugs and Vaccines Revenue by Type (2016-2021) & ($ million)
Table 12. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2016-2021)
Table 13. Global Pediatric Drugs and Vaccines Sale Price by Type (2016-2021)
Table 14. Global Pediatric Drugs and Vaccines Sales by Application (2016-2021) & (Kg)
Table 15. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021)
Table 16. Global Pediatric Drugs and Vaccines Value by Application (2016-2021)
Table 17. Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2016-2021)
Table 18. Global Pediatric Drugs and Vaccines Sale Price by Application (2016-2021)
Table 19. Global Pediatric Drugs and Vaccines Sales by Company (2019-2021) & (Kg)
Table 20. Global Pediatric Drugs and Vaccines Sales Market Share by Company (2019-2021)
Table 21. Global Pediatric Drugs and Vaccines Revenue by Company (2019-2021) ($ Millions)
Table 22. Global Pediatric Drugs and Vaccines Revenue Market Share by Company (2019-2021)
Table 23. Global Pediatric Drugs and Vaccines Sale Price by Company (2019-2021)
Table 24. Key Manufacturers Pediatric Drugs and Vaccines Producing Area Distribution and Sales Area
Table 25. Players Pediatric Drugs and Vaccines Products Offered
Table 26. Pediatric Drugs and Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Pediatric Drugs and Vaccines Sales by Region (2016-2021) (Kg)
Table 30. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2016-2021)
Table 31. Global Pediatric Drugs and Vaccines Revenue by Region (2016-2021) & ($ Millions)
Table 32. Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2016-2021)
Table 33. Americas Pediatric Drugs and Vaccines Sales by Country (2016-2021) & (Kg)
Table 34. Americas Pediatric Drugs and Vaccines Sales Market Share by Country (2016-2021)
Table 35. Americas Pediatric Drugs and Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 36. Americas Pediatric Drugs and Vaccines Revenue Market Share by Country (2016-2021)
Table 37. Americas Pediatric Drugs and Vaccines Sales by Type (2016-2021) & (Kg)
Table 38. Americas Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021)
Table 39. Americas Pediatric Drugs and Vaccines Sales by Application (2016-2021) & (Kg)
Table 40. Americas Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021)
Table 41. APAC Pediatric Drugs and Vaccines Sales by Region (2016-2021) & (Kg)
Table 42. APAC Pediatric Drugs and Vaccines Sales Market Share by Region (2016-2021)
Table 43. APAC Pediatric Drugs and Vaccines Revenue by Region (2016-2021) & ($ Millions)
Table 44. APAC Pediatric Drugs and Vaccines Revenue Market Share by Region (2016-2021)
Table 45. APAC Pediatric Drugs and Vaccines Sales by Type (2016-2021) & (Kg)
Table 46. APAC Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021)
Table 47. APAC Pediatric Drugs and Vaccines Sales by Application (2016-2021) & (Kg)
Table 48. APAC Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021)
Table 49. Europe Pediatric Drugs and Vaccines Sales by Country (2016-2021) & (Kg)
Table 50. Europe Pediatric Drugs and Vaccines Sales Market Share by Country (2016-2021)
Table 51. Europe Pediatric Drugs and Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 52. Europe Pediatric Drugs and Vaccines Revenue Market Share by Country (2016-2021)
Table 53. Europe Pediatric Drugs and Vaccines Sales by Type (2016-2021) & (Kg)
Table 54. Europe Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021)
Table 55. Europe Pediatric Drugs and Vaccines Sales by Application (2016-2021) & (Kg)
Table 56. Europe Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021)
Table 57. Middle East & Africa Pediatric Drugs and Vaccines Sales by Country (2016-2021) & (Kg)
Table 58. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Country (2016-2021)
Table 59. Middle East & Africa Pediatric Drugs and Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 60. Middle East & Africa Pediatric Drugs and Vaccines Revenue Market Share by Country (2016-2021)
Table 61. Middle East & Africa Pediatric Drugs and Vaccines Sales by Type (2016-2021) & (Kg)
Table 62. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021)
Table 63. Middle East & Africa Pediatric Drugs and Vaccines Sales by Application (2016-2021) & (Kg)
Table 64. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021)
Table 65. Key and Potential Regions of Pediatric Drugs and Vaccines
Table 66. Key Application and Potential Industries of Pediatric Drugs and Vaccines
Table 67. Key Challenges of Pediatric Drugs and Vaccines
Table 68. Key Trends of Pediatric Drugs and Vaccines
Table 69. Pediatric Drugs and Vaccines Distributors List
Table 70. Pediatric Drugs and Vaccines Customer List
Table 71. Global Pediatric Drugs and Vaccines Sales Forecast by Region (2021-2026) & (Kg)
Table 72. Global Pediatric Drugs and Vaccines Consumption Market Forecast by Region
Table 73. Global Pediatric Drugs and Vaccines Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Region (2021-2026)
Table 75. Americas Pediatric Drugs and Vaccines Sales Forecast by Country (2021-2026) & (Kg)
Table 76. Americas Pediatric Drugs and Vaccines Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. APAC Pediatric Drugs and Vaccines Sales Forecast by Region (2021-2026) & (Kg)
Table 78. APAC Pediatric Drugs and Vaccines Revenue Forecast by Region (2021-2026) & ($ millions)
Table 79. Europe Pediatric Drugs and Vaccines Sales Forecast by Country (2021-2026) & (Kg)
Table 80. Europe Pediatric Drugs and Vaccines Revenue Forecast by Country (2021-2026) & ($ millions)
Table 81. Middle East & Africa Pediatric Drugs and Vaccines Sales Forecast by Country (2021-2026) & (Kg)
Table 82. Middle East & Africa Pediatric Drugs and Vaccines Revenue Forecast by Country (2021-2026) & ($ millions)
Table 83. Global Pediatric Drugs and Vaccines Sales Forecast by Type (2021-2026) & (Kg)
Table 84. Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Type (2021-2026)
Table 85. Global Pediatric Drugs and Vaccines Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 86. Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Type (2021-2026)
Table 87. Global Pediatric Drugs and Vaccines Sales Forecast by Application (2021-2026) & (Kg)
Table 88. Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Application (2021-2026)
Table 89. Global Pediatric Drugs and Vaccines Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 90. Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Application (2021-2026)
Table 91. Merck & Co., Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 92. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Offered
Table 93. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 94. Merck & Co., Inc. (USA) Main Business
Table 95. Merck & Co., Inc. (USA) Latest Developments
Table 96. Abbott Laboratories (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 97. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Offered
Table 98. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 99. Abbott Laboratories (USA) Main Business
Table 100. Abbott Laboratories (USA) Latest Developments
Table 101. Amgen, Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 102. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Offered
Table 103. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 104. Amgen, Inc. (USA) Main Business
Table 105. Amgen, Inc. (USA) Latest Developments
Table 106. Eli Lilly and Company (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 107. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Offered
Table 108. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 109. Eli Lilly and Company (USA) Main Business
Table 110. Eli Lilly and Company (USA) Latest Developments
Table 111. F. Hoffmann-La Roche Ltd (Switzerland) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 112. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Offered
Table 113. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 114. F. Hoffmann-La Roche Ltd (Switzerland) Main Business
Table 115. F. Hoffmann-La Roche Ltd (Switzerland) Latest Developments
Table 116. Genentech, Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 117. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Offered
Table 118. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 119. Genentech, Inc. (USA) Main Business
Table 120. Genentech, Inc. (USA) Latest Developments
Table 121. GlaxoSmithKline plc. (UK) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 122. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Offered
Table 123. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 124. GlaxoSmithKline plc. (UK) Main Business
Table 125. GlaxoSmithKline plc. (UK) Latest Developments
Table 126. Janssen Biologics B.V. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 127. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Offered
Table 128. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 129. Janssen Biologics B.V. (USA) Main Business
Table 130. Janssen Biologics B.V. (USA) Latest Developments
Table 131. Actelion Pharmaceuticals Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 132. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Offered
Table 133. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 134. Actelion Pharmaceuticals Main Business
Table 135. Actelion Pharmaceuticals Latest Developments
Table 136. AstraZeneca Plc. (UK) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 137. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Offered
Table 138. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 139. AstraZeneca Plc. (UK) Main Business
Table 140. AstraZeneca Plc. (UK) Latest Developments
Table 141. Boehringer Ingelheim GmbH (Germany) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 142. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Offered
Table 143. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 144. Boehringer Ingelheim GmbH (Germany) Main Business
Table 145. Boehringer Ingelheim GmbH (Germany) Latest Developments
Table 146. Bristol-Myers Squibb Company (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 147. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Offered
Table 148. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 149. Bristol-Myers Squibb Company (USA) Main Business
Table 150. Bristol-Myers Squibb Company (USA) Latest Developments
Table 151. Allergan, Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 152. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Offered
Table 153. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 154. Allergan, Inc. (USA) Main Business
Table 155. Allergan, Inc. (USA) Latest Developments
Table 156. Novartis AG (Switzerland) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 157. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Offered
Table 158. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 159. Novartis AG (Switzerland) Main Business
Table 160. Novartis AG (Switzerland) Latest Developments
Table 161. Novo Nordisk A/S (Denmark) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 162. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Offered
Table 163. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 164. Novo Nordisk A/S (Denmark) Main Business
Table 165. Novo Nordisk A/S (Denmark) Latest Developments
Table 166. Pfizer, Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 167. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Offered
Table 168. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 169. Pfizer, Inc. (USA) Main Business
Table 170. Pfizer, Inc. (USA) Latest Developments
Table 171. Sanofi S.A (France) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 172. Sanofi S.A (France) Pediatric Drugs and Vaccines Product Offered
Table 173. Sanofi S.A (France) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 174. Sanofi S.A (France) Main Business
Table 175. Sanofi S.A (France) Latest Developments
Table 176. Shionogi Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 177. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Offered
Table 178. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 179. Shionogi Inc. (USA) Main Business
Table 180. Shionogi Inc. (USA) Latest Developments
Table 181. Takeda Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 182. Takeda Pediatric Drugs and Vaccines Product Offered
Table 183. Takeda Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 184. Takeda Main Business
Table 185. Takeda Latest Developments
List of Figures
Figure 1. Picture of Pediatric Drugs and Vaccines
Figure 2. Pediatric Drugs and Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pediatric Drugs and Vaccines Sales Growth Rate 2016-2026 (Kg)
Figure 7. Global Pediatric Drugs and Vaccines Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Pediatric Drugs and Vaccines Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Diphtheria
Figure 10. Product Picture of Influenza
Figure 11. Product Picture of Hepatitis
Figure 12. Product Picture of Pneumococcal Diseases
Figure 13. Product Picture of Meningococcal Diseases
Figure 14. Product Picture of Mumps
Figure 15. Product Picture of Others
Figure 16. Global Pediatric Drugs and Vaccines Sales Market Share by Type in 2020
Figure 17. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2016-2021)
Figure 18. Pediatric Drugs and Vaccines Consumed in Newborn
Figure 19. Global Pediatric Drugs and Vaccines Market: Newborn (2016-2021) & (Kg)
Figure 20. Pediatric Drugs and Vaccines Consumed in Infant
Figure 21. Global Pediatric Drugs and Vaccines Market: Infant (2016-2021) & (Kg)
Figure 22. Pediatric Drugs and Vaccines Consumed in Child
Figure 23. Global Pediatric Drugs and Vaccines Market: Child (2016-2021) & (Kg)
Figure 24. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021)
Figure 25. Global Pediatric Drugs and Vaccines Revenue Market Share by Application in 2020
Figure 26. Pediatric Drugs and Vaccines Revenue Market by Company in 2020 ($ Million)
Figure 27. Global Pediatric Drugs and Vaccines Revenue Market Share by Company in 2020
Figure 28. Global Pediatric Drugs and Vaccines Sales Market Share by Regions (2016-2021)
Figure 29. Global Pediatric Drugs and Vaccines Revenue Market Share by Region in 2020
Figure 30. Americas Pediatric Drugs and Vaccines Sales 2016-2021 (Kg)
Figure 31. Americas Pediatric Drugs and Vaccines Revenue 2016-2021 ($ Millions)
Figure 32. APAC Pediatric Drugs and Vaccines Sales 2016-2021 (Kg)
Figure 33. APAC Pediatric Drugs and Vaccines Revenue 2016-2021 ($ Millions)
Figure 34. Europe Pediatric Drugs and Vaccines Sales 2016-2021 (Kg)
Figure 35. Europe Pediatric Drugs and Vaccines Revenue 2016-2021 ($ Millions)
Figure 36. Middle East & Africa Pediatric Drugs and Vaccines Sales 2016-2021 (Kg)
Figure 37. Middle East & Africa Pediatric Drugs and Vaccines Revenue 2016-2021 ($ Millions)
Figure 38. Americas Pediatric Drugs and Vaccines Sales Market Share by Country in 2020
Figure 39. Americas Pediatric Drugs and Vaccines Revenue Market Share by Country in 2020
Figure 40. Americas Pediatric Drugs and Vaccines Sales Market Share by Type in 2020
Figure 41. Americas Pediatric Drugs and Vaccines Sales Market Share by Application in 2020
Figure 42. United States Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 43. Canada Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 44. Mexico Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 45. Brazil Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 46. APAC Pediatric Drugs and Vaccines Sales Market Share by Region in 2020
Figure 47. APAC Pediatric Drugs and Vaccines Revenue Market Share by Regions in 2020
Figure 48. APAC Pediatric Drugs and Vaccines Sales Market Share by Type in 2020
Figure 49. APAC Pediatric Drugs and Vaccines Sales Market Share by Application in 2020
Figure 50. China Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 51. Japan Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 52. Korea Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 53. Southeast Asia Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 54. India Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 55. Australia Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 56. Europe Pediatric Drugs and Vaccines Sales Market Share by Country in 2020
Figure 57. Europe Pediatric Drugs and Vaccines Revenue Market Share by Country in 2020
Figure 58. Europe Pediatric Drugs and Vaccines Sales Market Share by Type in 2020
Figure 59. Europe Pediatric Drugs and Vaccines Sales Market Share by Application in 2020
Figure 60. Germany Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 61. France Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 62. UK Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 63. Italy Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 64. Russia Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 65. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Country in 2020
Figure 66. Middle East & Africa Pediatric Drugs and Vaccines Revenue Market Share by Country in 2020
Figure 67. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Type in 2020
Figure 68. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Application in 2020
Figure 69. Egypt Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 70. South Africa Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 71. Israel Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 72. Turkey Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 73. GCC Country Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
